Table II.

Associations with Oral Pre-Exposure Prophylaxis Use and Discontinuation, and Interest in Long-Acting Injectable PrEP in Black Cisgender Sexual Minority Men

	Currently using oral PrEP		Discontinued oral PrEP		Acceptability of injectable PrEP
	RR [95% CI]	p	RR [95% CI]	p	RR [95% CI]	p
Sexual behavior
SMO	1.00 [1.00, 1.00]		1.00 [1.00, 1.00]		1.00 [1.00, 1.00]
SMW	.39 [.17, .89]	.025	1.82 [.90, 3.67]	.095	1.02 [.68, 1.55]	.911
PrEP
Currently using					1.00 [1.00, 1.00]
Discontinued use					.76 [.48, 1.20]	.238
Never used					.56 [.40, .79]	.001
	Currently using oral PrEP		Discontinued oral PrEP		Acceptability of injectable PrEP
	RR [95% CI]		RR [95% CI]		RR [95% CI]
Sexual Orientation Identity
Gay-identified	1.00 [1.00, 1.00]		1.00 [1.00, 1.00]		1.00 [1.00, 1.00]
Bisexual-identified	.52 [.29, .92]	.026	1.77 [.75, 4.15]	.192	1.01 [.70, 1.47]	.956
PrEP
Currently using					1.00 [1.00, 1.00]
Discontinued use					.76 [.48, 1.20]	.237
Never used					.56 [.40, .79]	.001
	Currently using oral PrEP		Discontinued oral PrEP		Acceptability of injectable PrEP
	RR [95% CI]		RR [95% CI]		RR [95% CI]
Sexual subgroup
Gay-identified, SMO	1.00 [1.00, 1.00]		1.00 [1.00, 1.00]		1.00 [1.00, 1.00]
Bisexual-identified SMO	.85 [.44, 1.65]	.632	1.32 [.42, 4.18]	.635	1.06 [.68, 1.66]	.781
Gay-identified, SMW	.89 [.36, 2.18]	.792	1.08 [.15, 7.56]	.937	1.20 [.60, 2.41]	.613
Bisexual-identified, SMW	.24 [.07, .76]	.015	2.50 [1.14, 5.50]	.022	.98 [.59, 1.62]	.939
PrEP
Currently using					1.00 [1.00, 1.00]
Discontinued use					.77 [.49, 1.20]	.246
Never used					.56 [.40, .79]	.001

RR = Relative Risk

PrEP = Pre-Exposure Prophylaxis

SMO = has had sex with men only in the past six months

SMW = has had sex with men and women in the past six months

All models adjusted for age, employment status, annual income (≥ $20,000 USD), Education (Highschool or higher), and Housing Stability.

Significant effects are bolded.